Search

everythinglearnresearchcommunity

for

Search:↓

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

Botanicals like green tea extract show potential for hair growth, but more research is needed.

Androgen receptor inactivation delays skin cancer onset and reduces incidence in mice, with gender differences in susceptibility.

PRP and LLLT can improve hair growth in AGA, but more research needed.

Cells from balding scalps have more androgen receptors than cells from non-balding scalps.

Minoxidil and finasteride treat hair loss; more research needed for other options.

Genes and hormones cause hair loss, with four genes contributing equally.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.

RU58841, a nonsteroidal anti-androgen, showed potential as a topical treatment for hair loss, increasing hair density, thickness, and length without systemic side effects in Stumptailed Macaques.

We need better ways to test and understand SARMs to make safer and more effective treatments.

AGA, a common hair loss, is caused by genetics, hormones, age, and environmental factors.

Dsg1 is essential for maintaining a healthy skin barrier in mice.

High levels of androgens during early development may cause PCOS-like symptoms.

Finasteride improves heart function and repairs damage after heart attack in mice.

Minoxidil does not work to inhibit lysyl hydroxylases in newborn mouse lungs.

Rhino mice show significant meibomian gland changes, making them a potential model for studying gland disorders.

The spiny mouse is a unique menstruating rodent that can help us understand menstruation and reproductive disorders.

Minoxidil treatment improves heart defects in a DiGeorge syndrome model.

The Foxn1(-/-) nude mouse shows disrupted and expanded skin stem cell areas due to high Lhx2 levels.

The research identified new skin traits in mice, some linked to human skin conditions.

Hair follicle studies suggest that maintaining telomere length could help treat hair loss and graying, but it's uncertain if mouse results apply to humans.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

The research found new potential mechanisms in mouse hair growth by studying RNA interactions.

Melanocyte pathology requires keratinocyte hyperplasia and regulation dysfunction.

Dutasteride may protect brain cells in early Parkinson's, while progesterone helps neuron recovery.

Setipiprant may reduce inflammation by blocking an enzyme called aldose reductase.

Ac-GFFY-IGF peptide is a promising, safe, and effective treatment for hair loss, better than current options.

Minoxidil helps hair growth by activating enzymes in hair follicles.

Moxibustion may help improve ovarian function by changing androgen levels.

Botulinum toxin A helped stop hair loss and grow new hair in mice.